Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01817010 · ClinicalTrials.gov registry record · NA

Strength and Function Following Total Hip Arthroplasty

A NA study of Total Hip Arthroplasty, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
68
Enrollment target
1
Study location

NCT01817010 is a NA study of Total Hip Arthroplasty that has completed, run by University of Colorado, Denver. The registered enrollment target is 68 participants, below the 139-participant average among 12 other Total Hip Arthroplasty trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01817010, a NA study of Total Hip Arthroplasty, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target
1
Study location

Study Summary

To determine if patients who receive an 8 week, comprehensive, multi-component rehabilitation program (CMC) have better strength and functional performance compared to a control group (CON). The investigators hypothesize that functional performance and strength in the muscles surrounding the hip and the knee will be greater in the multi-component rehabilitation group compared to the control group.

Conditions Studied

Interventions

  • BEHAVIORAL Multi-Component Rehabilitation (CMC)
  • BEHAVIORAL Control (CON)

Study Locations (1)

Colorado

  • University of Colorado Denver, Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2012-09
Est. Completion 2015-12
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT01817010

The ClinicalTrials.gov registry entry for NCT01817010 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 139-participant average among 12 other Total Hip Arthroplasty trials with a reported enrollment target (51% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Total Hip Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which Multi-Component Rehabilitation (CMC) is the first listed.

NCT01817010 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT01817010 about?

NCT01817010 is a clinical study titled "Strength and Function Following Total Hip Arthroplasty". To determine if patients who receive an 8 week, comprehensive, multi-component rehabilitation program (CMC) have better strength and functional performance compared to a control group (CON). The investigators hypothesize that functional performance and strength in the muscles surrounding the hip an...

What is the current status of trial NCT01817010?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2012-09. Estimated completion is 2015-12.

What conditions does trial NCT01817010 study?

This clinical trial studies the following conditions: Total Hip Arthroplasty.

What interventions are being tested in trial NCT01817010?

The interventions under investigation include: Multi-Component Rehabilitation (CMC) (BEHAVIORAL), Control (CON) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01817010?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01817010 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Total Hip Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.